Renowned Ophthalmology Leaders to Join CellViva Board of Directors

SAN FRANCISCO--(BUSINESS WIRE)--CellViva, a biopharmaceutical company pioneering the development of an innovative anti-VEGF therapy for pterygium—an unmet medical need in ophthalmology, is proud to announce the appointment of three distinguished leaders in ophthalmology to its Board of Directors: Drs. Adrienne Graves, Kathryn Najafi-Tagol, and Richard Lindstrom. Meet the New Board Members Dr. Adrienne Graves: Former Board Chair of Iveric Bio, Dr. Graves brings decades of experience in clinical